52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience F.J. Melgosa Ramos, A. Mateu Puchades, J. Matáix-Díaz, L. Schneller-Pavelescu, I. Belinchón-Romero, S. Santos Alarcón

Efficacy and Pharmacoeconomic Analysis in Real Clinical Practice Conditions of Patients with Plaque Psoriasis Treated with Guselkumab: A Retrospective Multicenter Study R. Ruiz-Villaverde, M. Galan-Gutierrez, J.C. Armario-Hita, L. Rodriguez-Fernandez-Freire

Real-World Experience of Secukinumab Dose Optimization in Moderate-to-Severe Psoriasis. Retrospective, Single-Center Series of 11-Patients Á. Aguado Vázquez, F.J. Melgosa Ramos, C. Alonso Díez, A. Mateu Puchades